Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

A webcast of the presentation will be live and archived on the News & Events section of the company website.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Thursday, October 20, 2022

Information

Tags:

Skin, News, PDT, BFRI, Impetigo, Financial services, Pharmaceutical industry

Geotags:

WOBURN, MASSACHUSETTS, US

⚠ partially generated by AI ↴

Summary

Key Points:

A webcast of the presentation will be live and archived on the News & Events section of the company website.
Institutional investors registered for the conference who would like to meet with Erica Monaco and Hermann Lbbert, Executive Chairman of Biofrontera Inc., please contact LD Micro directly or the BFRI investor relations team.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics.
The Companys licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will be presenting and meeting with registered investors at the LD Micro Main Event XV that will be held October 25-27, 2022 at the Luxe Sunset Boulevard Hotel in Southern California.

Event:	LD Micro Main Event XV
Date:	Wednesday, October 26, 2022
Presentation Time:	4:00 PM Pacific Time (7:00 PM Eastern Time)
Location:	Luxe Sunset Boulevard Hotel, Los Angeles, CA
Webcast:	https://me22.sequireevents.com

A webcast of the presentation will be live and archived on the News & Events section of the company website. Institutional investors registered for the conference who would like to meet with Erica Monaco and Hermann Lübbert, Executive Chairman of Biofrontera Inc., please contact LD Micro directly or the BFRI investor relations team.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
[email protected]

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
[email protected]

# # #